Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
100.58
+2.31 (2.35%)
At close: Nov 24, 2025, 4:00 PM EST
100.58
0.00 (0.00%)
After-hours: Nov 24, 2025, 7:00 PM EST
Revvity Revenue
Revvity had revenue of $698.95M in the quarter ending September 28, 2025, with 2.18% growth. This brings the company's revenue in the last twelve months to $2.81B, up 3.37% year-over-year. In the year 2024, Revvity had annual revenue of $2.76B with 0.16% growth.
Revenue (ttm)
$2.81B
Revenue Growth
+3.37%
P/S Ratio
4.24
Revenue / Employee
$255,761
Employees
11,000
Market Cap
11.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
| Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
| Dec 30, 2018 | 2.78B | 521.01M | 23.08% |
| Dec 31, 2017 | 2.26B | 141.47M | 6.69% |
| Jan 1, 2017 | 2.12B | 10.69M | 0.51% |
| Jan 3, 2016 | 2.10B | 34.94M | 1.69% |
| Dec 28, 2014 | 2.07B | -87.71M | -4.07% |
| Dec 29, 2013 | 2.16B | 52.40M | 2.49% |
| Dec 30, 2012 | 2.11B | 186.68M | 9.73% |
| Jan 1, 2012 | 1.92B | 216.74M | 12.74% |
| Jan 2, 2011 | 1.70B | 151.00M | 9.74% |
| Jan 3, 2010 | 1.55B | - | - |
| Dec 28, 2008 | 0 | - | - |
| Dec 30, 2007 | 0 | - | - |
| Dec 31, 2006 | 0 | - | - |
| Jan 1, 2006 | 0 | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
RVTY News
- 6 days ago - Revvity, Inc. (RVTY) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Revvity, Inc. (RVTY) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 14 days ago - Revvity Collaborates with MDIC and NIST to Launch New Somatic Cancer Reference Standards to Monitor Diagnostic Assay Accuracy - Business Wire
- 14 days ago - Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities - Business Wire
- 27 days ago - Revvity Analysts Increase Their Forecasts After Q3 Earnings - Benzinga
- 27 days ago - Revvity to Present at Upcoming Investor Conferences - Business Wire
- 4 weeks ago - Revvity: Software Momentum And Screening Offset China Weakness - Seeking Alpha
- 4 weeks ago - Revvity, Inc. (RVTY) Q3 2025 Earnings Call Transcript - Seeking Alpha